-+ 0.00%
-+ 0.00%
-+ 0.00%

aTyr Pharma Q2 EPS $(0.11) Beats $(0.12) Estimate

Benzinga·08/07/2026 20:02:11
Listen to the news
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 50 percent increase over losses of $(0.22) per share from the same period last year.